<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>21(2)</volume><submitter>Li J</submitter><pubmed_abstract>The post-coronavirus disease 2019 (COVID-19) pulmonary sequelae have garnered public concern. We conducted a multicenter cross-sectional study in outpatient and health exam populations from 23 clinical centers (including university-affiliated/provincial general hospitals, municipal general hospitals, county hospitals, and specialized hospitals) in China (2019-2023), to assess temporal trends and potential influencing factors in the detection of CT-diagnosed pulmonary nodules, pleural effusion, pneumonia, and suspected lung tumors, cancer and viral pneumonia, clarifying pandemic impacts on lung health. Dynamic comparisons across key phases including initial outbreak, vaccine rollout, population-wide vaccination, and major adjustment of pandemic control policies, were performed. This study a</pubmed_abstract><journal>PloS one</journal><pagination>e0343207</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12923060</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Trends and associations of pulmonary nodule detection rates in China, 2019-2023: A multicenter cross-sectional study based on Real-World Data.</pubmed_title><pmcid>PMC12923060</pmcid><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Liao Y</pubmed_authors><pubmed_authors>Ming M</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Li C</pubmed_authors><pubmed_authors>Liu M</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Zhou S</pubmed_authors><pubmed_authors>Xie Z</pubmed_authors><pubmed_authors>Xu Q</pubmed_authors><pubmed_authors>Chen H</pubmed_authors><pubmed_authors>Guo S</pubmed_authors><pubmed_authors>Meng Z</pubmed_authors><pubmed_authors>Hou Y</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Jin G</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Huang X</pubmed_authors><pubmed_authors>Lin H</pubmed_authors><pubmed_authors>Liang L</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Deng W</pubmed_authors><pubmed_authors>Wu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Trends and associations of pulmonary nodule detection rates in China, 2019-2023: A multicenter cross-sectional study based on Real-World Data.</name><description>The post-coronavirus disease 2019 (COVID-19) pulmonary sequelae have garnered public concern. We conducted a multicenter cross-sectional study in outpatient and health exam populations from 23 clinical centers (including university-affiliated/provincial general hospitals, municipal general hospitals, county hospitals, and specialized hospitals) in China (2019-2023), to assess temporal trends and potential influencing factors in the detection of CT-diagnosed pulmonary nodules, pleural effusion, pneumonia, and suspected lung tumors, cancer and viral pneumonia, clarifying pandemic impacts on lung health. Dynamic comparisons across key phases including initial outbreak, vaccine rollout, population-wide vaccination, and major adjustment of pandemic control policies, were performed. This study a</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026</publication><modification>2026-07-16T13:00:08.274Z</modification><creation>2026-07-09T10:57:06.041Z</creation></dates><accession>S-EPMC12923060</accession><cross_references><pubmed>41719243</pubmed><doi>10.1371/journal.pone.0343207</doi></cross_references></HashMap>